The global market for immunoprotein diagnostic testing is likely to showcase prominent growth over the period from 2020 to 2027, states a new report by Report Ocean. The report, titled “Global Immunoprotein Diagnostic Testing Market Size study, by Type (C-reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Pre-albumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test and Free Light Chain Diagnostic Test), by Application (Autoimmune Testing, Infectious Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing and Toxicology Testing), by Technology (Radioimmunoassay, Immunoturbidity Assay, Immunoprotein Electrophoresis, Enzyme-linked immunosorbent assay and Others) and Regional Forecasts 2020-2027,” is prepared by analyzing this market thoroughly and assessing all its segments at length.
With the increasing prevalence of chronic diseases, such as diabetes, arthritis, heart disorders, kidney disease, the global immunoprotein diagnostic testing market is witnessing a surge in its valuation. The overall valuation of the market was US$10.1 billion in 2019. The research report expects this market to rise at a CAGR of more than 6.6% over the forecast period 2020-2027. The ever-rising geriatric population and the augmenting demand for early diagnostic services are significantly supporting the immunoprotein diagnostic testing market, worldwide. On the flip side, the presence of stringent regulations related to the immunoprotein diagnostic testing procedures may inhibit the growth of this market over the next few years. However, the increasing incidence of viral infections, most recently the Covid 19, has concerned people about their immunity, which is expected to boost this market considerably during the forecast period, states the research study.
The geographical assessment of the global immunoprotein diagnostic testing market has also given in this research study. According to it, the market is mainly spread across Asia Pacific, North America, Europe, Latin America, and the Rest of the World. The leading market for immunoprotein diagnostic testing across the world is North America and this market is projected to remain on the top over the next few years. The rise in the demand for quick diagnostic services to diagnose chronic diseases, current trend of preventive healthcare, the increasing number of drug abuse, and the surge in allergy cases, collectively, are adding substantial growth to this market. Asia Pacific is another regional market to witness a high growth rate over the years to come, reports the market study.
Impact of Covid 19 on Immunoprotein Diagnostic Testing Market
The global immunoprotein diagnostic testing is one of the few markets that have been positively impacted by the Coronavirus pandemic. The increased concerns among people regarding the virus, its impact, and the vulnerability of chronic patients against it, has augmented the emphasis on immunity and, consequently, on immunoprotein diagnostic testing.
- The leading market for immunoprotein diagnostic testing across the world is North America and is projected to remain on the top over the next few years.
- Asia Pacific is another regional market to witness a high growth rate over the years to come.
- C-reactive Protein Diagnostic Test
- Complement System Protein Diagnostic Test
- Pre-albumin Diagnostic Test
- Haptoglobin Diagnostic Test
- Immunoglobulin Diagnostic Test
- Free Light Chain Diagnostic Test
- Autoimmune Testing
- Infectious Disease Testing
- Allergy Testing
- Endocrine Testing
- Oncology Testing
- Toxicology Testing
- Immunoturbidity Assay
- Immunoprotein Electrophoresis
- Enzyme-linked immunosorbent assay
- North America
- Asia Pacific
- Latin America
- Rest of the World
Companies Mentioned in the Report
- Abbott Laboratories
- Abcam PLC
- Bio-Rad Laboratories
- Danaher Corporation
- Diasorin, Enzo Life Sciences
- Ortho Clinical Diagnostics
- Roche Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific
Company Name: Report Ocean
Contact Person: Nishi Sharma
Email: Send Email
Address:BSI Business Park,H-15, Sector-63, Noida
State: UP, 201301